Columbia Lab to Market Accelerator Network - Cloned

Dr. Harmen Bussemaker and his research team are building a platform that allows the design of useful molecular reagents by measuring molecular interactions in ultra-high throughput environments.#innovation #therapeutics #accelerator

Read here: https://t.co/nR5P5ejhZw

— Columbia Lab-to-Market Accelerator Network (@Columbia_L2M) July 5, 2020

@Columbia_L2M's latest Founder's Spotlight is on Deniz Vurmaz, NYCML Combine alum and founder of LostBytes, a sustainable waste #startup that uses proprietary bio-digester machinery to produce organic fertilizer for plants 🌱 https://t.co/3vy8zGO9n7 pic.twitter.com/kUcuCIQT6C

— NYC Media Lab (@nycmedialab) June 10, 2020

Now in its 8th year, BiomedX has received over 150 applications and funded 50 teams for $4.5M cumulatively.

Collectively, the 50 funded teams have generated over $72M in follow-on funding.

Projects to date:https://t.co/DB1BFXJVdI

— Columbia Lab-to-Market Accelerator Network (@Columbia_L2M) April 13, 2020